A pilot experience with permanent biventricular pacing to treat advanced heart failure.

BACKGROUND The prognosis and quality of life of patients with advanced heart failure remain poor. The purpose of this study was to evaluate new nonpharmacologic approaches. Biventricular pacing was proposed in this indication, based on the encouraging results of acute hemodynamics studies. METHODS Fifty patients with drug-resistant heart failure (New York Heart Association [NYHA] class III/IV, 16 of 34) were consecutively implanted with biventricular pacemakers. All patients had severe dilated cardiomyopathy and intraventricular conduction delay. Survival, NYHA class, electrocardiogram, echocardiographic data, and exercise tolerance were assessed over a mean follow-up period of 15.4 +/- 10. 2 months. RESULTS At the end of follow-up, 55% of patients were alive without heart transplantation or left ventricular assistance device. The mortality rate was significantly lower in class III (12. 5%) than in class IV patients (52.5%). In survivors, biventricular pacing significantly improved symptoms (NYHA class 2.2 +/- 0.5 at follow-up vs 3.7 +/- 0.5 at baseline) and exercise tolerance ((. )VO(2) peak 15.5 +/- 3.4 mL/min per kilogram at follow-up vs 11.1 +/- 3 mL/min per kilogram at baseline). CONCLUSIONS Biventricular pacing appears to improve the functional status of patients with dilated cardiomyopathy with advanced heart failure. The technique appears to be attractive as an additive treatment, especially in class III patients. Controlled randomized studies are needed to validate this novel concept.

[1]  C. Leclercq,et al.  Hemodynamic importance of preserving the normal sequence of ventricular activation in permanent cardiac pacing. , 1995, American heart journal.

[2]  C M O'Connor,et al.  Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group. , 1996, The New England journal of medicine.

[3]  E. Foster,et al.  Acute Effects of Intraoperative Multisite Ventricular Pacing on Left Ventricular Function and Activation/Contraction Sequence in Patients with Depressed Ventricular Function , 1998, Journal of cardiovascular electrophysiology.

[4]  R. Virmani,et al.  Serial electrocardiographic changes in idiopathic dilated cardiomyopathy confirmed at necropsy. , 1988, The American journal of cardiology.

[5]  M. Rosenqvist,et al.  Relative importance of activation sequence compared to atrioventricular synchrony in left ventricular function. , 1991, The American journal of cardiology.

[6]  A. Tajik,et al.  Mechanism of hemodynamic improvement by dual-chamber pacing for severe left ventricular dysfunction: an acute Doppler and catheterization hemodynamic study. , 1995, Journal of the American College of Cardiology.

[7]  C. H. Chen,et al.  Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. , 1999, Circulation.

[8]  M. Fisher,et al.  Dual-chamber pacing with a short atrioventricular delay in congestive heart failure: a randomized study. , 1995, Journal of the American College of Cardiology.

[9]  D G Gibson,et al.  Effects of abnormal activation on the time course of the left ventricular pressure pulse in dilated cardiomyopathy , 1992, British heart journal.

[10]  K. Swedberg,et al.  Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). , 1988, The American journal of cardiology.

[11]  C. Leclercq,et al.  Optimal right ventricular pacing site in chronically implanted patients: a prospective randomized crossover comparison of apical and outflow tract pacing. , 1999, Journal of the American College of Cardiology.

[12]  J. Schwartz,et al.  Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. , 1996, Circulation.

[13]  G. Dangas,et al.  A prolonged QRS duration on surface electrocardiogram is a specific indicator of left ventricular dysfunction [see comment]. , 1998, Journal of the American College of Cardiology.

[14]  J. Deharo,et al.  Multisite Pacing as a Supplemental Treatment of Congestive Heart Failure: Preliminary Results of the Medtronic Inc. InSync Study , 1998, Pacing and clinical electrophysiology : PACE.

[15]  J. Daubert,et al.  Four Chamber Pacing in Dilated Cardiomyopathy , 1994, Pacing and clinical electrophysiology : PACE.

[16]  J. Blanc,et al.  Evaluation of different ventricular pacing sites in patients with severe heart failure: results of an acute hemodynamic study. , 1997, Circulation.

[17]  B. Pitt,et al.  The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. , 1999, The New England journal of medicine.

[18]  M. Cline.  Book Review Blood: Principles and practice of hematology Edited by Robert I. Handin, Samuel E. Lux, and Thomas P. Stossel. 2304 pp., illustrated. Philadelphia, Lippincott–Raven, 1995. $169.95. 0-397-50944-8 , 1996 .

[19]  J. Ross,et al.  Diastolic mitral regurgitation in patients with atrioventricular conduction abnormalities: a common finding by Doppler echocardiography. , 1986, Journal of the American College of Cardiology.

[20]  J. Blanc,et al.  A Method for Permanent Transvenous Left Ventricular Pacing , 1998, Pacing and clinical electrophysiology : PACE.

[21]  Fach,et al.  Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) , 1999, The Lancet.

[22]  M. Gold,et al.  Prognostic value of the signal-averaged electrocardiogram and a prolonged QRS in ischemic and nonischemic cardiomyopathy. , 1995, The American journal of cardiology.

[23]  J. Cohn,et al.  The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. , 1996, The New England journal of medicine.

[24]  M. Rosenqvist,et al.  Results of atrioventricular synchronous pacing with optimized delay in patients with severe congestive heart failure. , 1995, The American journal of cardiology.

[25]  A. Lazarus,et al.  Multisite Pacing for End‐Stage Heart Failure: Early Experience , 1996, Pacing and clinical electrophysiology : PACE.

[26]  M. Komajda,et al.  Risk stratification in chronic heart failure. , 1998, European heart journal.

[27]  W. Stevenson,et al.  Improving survival for patients with advanced heart failure: a study of 737 consecutive patients. , 1995, Journal of the American College of Cardiology.

[28]  D. Andresen,et al.  First- or second-degree atrioventricular block as a risk factor in idiopathic dilated cardiomyopathy. , 1993, The American journal of cardiology.

[29]  CIBIS-II Investigators and Committees.  The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial , 1999, The Lancet.

[30]  H Le Breton,et al.  Acute hemodynamic effects of biventricular DDD pacing in patients with end-stage heart failure. , 1998, Journal of the American College of Cardiology.

[31]  Andrew P. Kramer,et al.  Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. The Pacing Therapies for Congestive Heart Failure Study Group. The Guidant Congestive Heart Failure Research Group. , 1999, Circulation.

[32]  J. Daubert,et al.  Permanent Left Ventricular Pacing With Transvenous Leads Inserted Into The Coronary Veins , 1998, Pacing and clinical electrophysiology : PACE.

[33]  R. Siegel,et al.  Patients who die awaiting heart transplantation. , 1993, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[34]  C. Ng,et al.  Usefulness of physiologic dual-chamber pacing in drug-resistant idiopathic dilated cardiomyopathy. , 1990, The American journal of cardiology.

[35]  M. Gold,et al.  Acute hemodynamic effects of atrio-biventricular pacing in humans. , 1995, The Annals of thoracic surgery.